Published in Ann Rheum Dis on March 16, 2013
Increase of hemoglobin levels by anti-IL-6 receptor antibody (tocilizumab) in rheumatoid arthritis. PLoS One (2014) 0.85
A Study on Association between Common Haematological Parameters and Disease Activity in Rheumatoid Arthritis. J Clin Diagn Res (2017) 0.75
Rheumatoid arthritis: anaemia independently predicts joint erosion in RA. Nat Rev Rheumatol (2013) 0.75
Prevalence of selected organ-specific autoantibodies in rheumatoid arthritis and primary Sjögren's syndrome patients. Reumatologia (2015) 0.75
Skin Manifestations of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritides. Clin Rev Allergy Immunol (2017) 0.75
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum (1995) 26.94
Anemia of chronic disease. N Engl J Med (2005) 10.88
The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum (1993) 8.73
Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum (2004) 7.13
The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood (2005) 5.58
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. Lancet (2010) 5.05
An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum (2008) 4.25
Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum (2010) 3.84
The prevalence of anaemia in the world. World Health Stat Q (1985) 3.64
Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ. Br J Rheumatol (1996) 3.63
The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol (2005) 3.28
Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade. Ann Rheum Dis (2008) 2.45
Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum (2011) 2.38
Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. Ann Rheum Dis (1992) 2.26
Anemia and renal function in patients with rheumatoid arthritis. J Rheumatol (2006) 2.25
Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-κB-inducible immune pathways. Immunity (2011) 2.20
Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol (2002) 2.01
Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology (2001) 1.88
Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol (2007) 1.72
Trends in treatment and outcomes of rheumatoid arthritis in Germany 1997-2007: results from the National Database of the German Collaborative Arthritis Centres. Ann Rheum Dis (2010) 1.68
Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci U S A (2003) 1.65
Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden. Ann Rheum Dis (2010) 1.41
Baseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient register. Ann Rheum Dis (2005) 1.36
A new method of scoring radiographic change in rheumatoid arthritis. J Rheumatol (1998) 1.35
Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies. Arthritis Rheum (2008) 1.32
Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthritis Rheum (2008) 1.25
Clinical quality management in rheumatoid arthritis: putting theory into practice. Swiss Clinical Quality Management in Rheumatoid Arthritis. Rheumatology (Oxford) (2000) 1.23
A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for rheumatoid arthritis structural severity. Arthritis Rheum (2006) 1.17
The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritis. Ann Rheum Dis (2010) 1.15
Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature. Am J Med (2004) 1.08
Greater likelihood of remission in rheumatoid arthritis patients treated earlier in the disease course: results from the Consortium of Rheumatology Researchers of North America registry. Arthritis Care Res (Hoboken) (2011) 1.04
Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. J Rheumatol (2001) 1.04
Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials. Semin Arthritis Rheum (2008) 1.03
Inhibition of human colony-forming-unit erythroid by tumor necrosis factor requires accessory cells. J Clin Invest (1990) 0.97
Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality. J Rheumatol (2008) 0.97
Erythropoietin reduces the degree of arthritis caused by type II collagen in the mouse. Arthritis Rheum (2005) 0.95
Anemia in the elderly. Curr Opin Hematol (2012) 0.93
Distinct ACPA fine specificities, formed under the influence of HLA shared epitope alleles, have no effect on radiographic joint damage in rheumatoid arthritis. Ann Rheum Dis (2011) 0.87
Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial. Ann Rheum Dis (1996) 0.85
Serum hepcidin level is not an independent surrogate biomarker of disease activity or of radiographic progression in rheumatoid arthritis: results from the ESPOIR cohort. Ann Rheum Dis (2012) 0.81
Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists. Ann Rheum Dis (2012) 0.80
A case-control study of anaemia in patients with rheumatoid arthritis treated with disease-modifying antirheumatic drugs in an adult population in the US: prevalence and impact on healthcare utilisation. J Med Econ (2008) 0.77
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ (2011) 6.89
Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ (2010) 5.68
Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial. Arthritis Rheum (2007) 3.22
A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries. Semin Arthritis Rheum (2010) 2.88
Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series. Swiss Med Wkly (2011) 2.46
Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysis. Arthritis Rheum (2007) 2.37
Induction of severe systemic lupus erythematosus by TNF blockade and response to anti-IL-6 strategy. J Allergy Clin Immunol (2012) 2.09
Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum (2009) 2.03
Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review. Arthritis Res Ther (2009) 1.98
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Ann Rheum Dis (2012) 1.78
Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort. Arthritis Rheum (2013) 1.67
EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology. Ann Rheum Dis (2010) 1.63
Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis. Arthritis Rheum (2009) 1.58
Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loop. PLoS Biol (2010) 1.56
Diagnostic value of sonography in patients with suspected carpal tunnel syndrome: a prospective study. Arthritis Rheum (2005) 1.54
Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies. Swiss Med Wkly (2009) 1.48
Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment. Blood (2005) 1.48
Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center. Arthritis Rheum (2011) 1.48
Recommendations for the use of ultrasound in rheumatoid arthritis: literature review and SONAR score experience. Swiss Med Wkly (2013) 1.41
Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptors. J Exp Med (2006) 1.32
Management of RA medications in pregnant patients. Nat Rev Rheumatol (2009) 1.17
The murine Fgfrl1 receptor is essential for the development of the metanephric kidney. Dev Biol (2009) 1.17
The remission of rheumatoid arthritis during pregnancy. Semin Immunopathol (2007) 1.15
Inflammation-associated autophagy-related programmed necrotic death of human neutrophils characterized by organelle fusion events. J Immunol (2011) 1.15
Tolerance and effectiveness of anti-tumor necrosis factor alpha therapies in elderly patients with rheumatoid arthritis: a population-based cohort study. Arthritis Rheum (2007) 1.13
Inhibition of IL-1, IL-6, and TNF-alpha in immune-mediated inflammatory diseases. Springer Semin Immunopathol (2006) 1.11
The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study. Rheumatology (Oxford) (2011) 1.06
T cell-regulated neutrophilic inflammation in autoinflammatory diseases. J Immunol (2005) 1.05
Class-switched B cells display response to therapeutic B-cell depletion in rheumatoid arthritis. Arthritis Res Ther (2009) 1.04
Immunology of pregnancy-pregnancy as a remission inducing agent in rheumatoid arthritis. Transpl Immunol (2002) 1.02
Preliminary validation of PRISM (Pictorial Representation of Illness and Self Measure) - a brief method to assess suffering. Psychother Psychosom (2002) 0.99
A systematic review of infliximab in the treatment of early rheumatoid arthritis. Ther Clin Risk Manag (2007) 0.98
Radiographic joint space width in the fingers of patients with rheumatoid arthritis of less than one year's duration. Arthritis Rheum (2006) 0.98
Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients. Ann Rheum Dis (2012) 0.97
Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy. Swiss Med Wkly (2007) 0.97
Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum (2010) 0.97
Interaction of pregnancy and autoimmune rheumatic disease. Autoimmun Rev (2011) 0.96
Pain as an important predictor of psychosocial health in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2012) 0.95
Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency. Arthritis Res Ther (2013) 0.95
The complex clinical picture of side effects to biologicals. Med Clin North Am (2010) 0.94
Spontaneous secretion of interleukin-17 and -22 by human cervical cells in Chlamydia trachomatis infection. Microbes Infect (2010) 0.94
Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study. Rheumatology (Oxford) (2011) 0.93
Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients. Arthritis Res Ther (2010) 0.93
Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission. J Rheumatol (2003) 0.92
Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders. Swiss Med Wkly (2002) 0.92
Scleroderma renal crisis: a rare but severe complication of systemic sclerosis. Clin Rev Allergy Immunol (2011) 0.92
Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus. Arthritis Rheum (2005) 0.91
Behçet's disease: successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis. Arthritis Care Res (Hoboken) (2012) 0.91
Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial. Arthritis Res Ther (2014) 0.91
Patients with diffuse idiopathic skeletal hyperostosis do not have increased peripheral bone mineral density and geometry. Rheumatology (Oxford) (2010) 0.90
Adalimumab in severe and acute sciatica: a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2010) 0.90
Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis. Ann Rheum Dis (2010) 0.89
Serum Dkk-1 levels of DISH patients are not different from healthy controls. Joint Bone Spine (2011) 0.89
Use of abatacept in rheumatoid arthritis. Swiss Med Wkly (2012) 0.88
How safe are anti-rheumatic drugs during pregnancy? Curr Opin Pharmacol (2013) 0.87
Cardiovascular risks of cyclooxygenase-2 inhibitors: where we stand now. Ann Intern Med (2005) 0.87
Measuring finger joint cartilage by ultrasound as a promising alternative to conventional radiograph imaging. Arthritis Rheum (2009) 0.86
Natural variations at position 93 of the invariant Vα24-Jα18 α chain of human iNKT-cell TCRs strongly impact on CD1d binding. Eur J Immunol (2011) 0.86
Association of bone attrition with knee pain, stiffness and disability: a cross-sectional study. Ann Rheum Dis (2010) 0.85
Reduced trabecular bone mineral density and cortical thickness accompanied by increased outer bone circumference in metacarpal bone of rheumatoid arthritis patients: a cross-sectional study. Arthritis Res Ther (2010) 0.85
Do synovial leptin levels correlate with pain in end stage arthritis? Int Orthop (2013) 0.84
Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-Analysis. J Manag Care Spec Pharm (2015) 0.84
Isometric rate of force development, maximum voluntary contraction, and balance in women with and without joint hypermobility. Arthritis Rheum (2008) 0.84
Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee. Int Orthop (2014) 0.83
Effectiveness of individual resource-oriented joint protection education in people with rheumatoid arthritis. A randomized controlled trial. Patient Educ Couns (2010) 0.83
Patient repositioning reproducibility of joint space width measurements on hand radiographs. Arthritis Care Res (Hoboken) (2011) 0.83
The economics of treatment in early rheumatoid arthritis. Best Pract Res Clin Rheumatol (2009) 0.83
Six and 12 months' effects of individual joint protection education in people with rheumatoid arthritis: a randomized controlled trial. Scand J Occup Ther (2011) 0.82
Influence of cytokine inhibitors on concentration and activity of MMP-1 and MMP-3 in disc herniation. Arthritis Res Ther (2009) 0.82
Clinical diagnosis compared to classification criteria in in a cohort of 54 patients with systemic sclerosis and associated disorders. Swiss Med Wkly (2007) 0.82
BMI and severity of clinical and radiographic signs of hip osteoarthritis. Obesity (Silver Spring) (2009) 0.82
Genetic evidence supporting the association of protease and protease inhibitor genes with inflammatory bowel disease: a systematic review. PLoS One (2011) 0.82
Reactivation of rheumatoid arthritis after pregnancy: increased phagocyte and recurring lymphocyte gene activity. Arthritis Rheum (2008) 0.82
Pregnancy and reproduction in autoimmune rheumatic diseases. Rheumatology (Oxford) (2010) 0.82
Hepatoprotective effect of tumour necrosis factor alpha blockade in psoriatic arthritis: a cross-sectional study. Ann Rheum Dis (2009) 0.82
Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study. Inflamm Bowel Dis (2015) 0.81
Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease. J Rheumatol (2007) 0.81
Cost-effectiveness of biologics in early rheumatoid arthritis. Ann Intern Med (2010) 0.81
Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort. Rheumatology (Oxford) (2013) 0.81
Treatment with biologics of pregnant patients with rheumatic diseases. Curr Opin Rheumatol (2011) 0.80
Anti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis: bayes clears the haze. Ann Intern Med (2007) 0.80
Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis. Arthritis Rheum (2011) 0.80
The importance of early treatment for the prognosis of rheumatoid arthritis. Swiss Med Wkly (2013) 0.79
Swiss consensus statement: Recommendations for optimising re-treatment with MabThera (rituximab) in rheumatoid arthritis. Swiss Med Wkly (2010) 0.79
No evidence for competition between cytotoxic T-lymphocyte responses in HIV-1 infection. Proc Biol Sci (2009) 0.79
Evaluation of histologic, serologic, and clinical changes in response to abatacept treatment of primary Sjögren’s syndrome: a pilot study. Arthritis Care Res (Hoboken) (2013) 0.79
Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate. J Rheumatol (2003) 0.79
Influence of pregnancy on the adipocytokine and peroxisome proliferator-activated receptor pathways in peripheral blood mononuclear cells from healthy donors and rheumatoid arthritis patients. Arthritis Rheum (2012) 0.79
Pregnancy mediated improvement of rheumatoid arthritis. Swiss Med Wkly (2012) 0.78
Abnormal bone geometry at the metacarpal bone shaft of rheumatoid arthritis patients with maintained muscle-bone relationship. Arthritis Care Res (Hoboken) (2010) 0.78
Cytokines and pregnancy in rheumatic disease. Ann N Y Acad Sci (2006) 0.78
Neutral functional realignment orthosis prevents hand pain in patients with subacute stroke: a randomized trial. Arch Phys Med Rehabil (2008) 0.78
Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion. Rheumatology (Oxford) (2010) 0.78